{"DataElement":{"publicId":"6345668","version":"1","preferredName":"IDH Gene Family Mutation Abnormality Status","preferredDefinition":"Text term to describe the patient's overall gene mutation status for the IDH family of genes.","longName":"IDH_GENE_FML_MUTA_ABN_ST","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"6345664","version":"1","preferredName":"IDH Gene Family Mutation Abnormality","preferredDefinition":"A family of genes that encode enzymes that catalyze the decarboxylation of isocitrate yielding alpha-ketoglutarate and carbon dioxide. Alpha-ketoglutarate is a precursor used in the synthesis of alanine, glutamine and pyruvate, and is an important intermediate in the citric acid cycle, which is an essential metabolic pathway used by cells to produce energy through aerobic respiration. Mutations in the IDH1 and IDH2 genes are associated with several types of brain tumors._Any change in the DNA of a cell. Mutations may be caused by mistakes during cell division, or they may be caused by exposure to DNA-damaging agents in the environment. Mutations can be harmful, beneficial, or have no effect. If they occur in cells that make eggs or sperm, they can be inherited; if mutations occur in other types of cells, they are not inherited. Certain mutations may lead to cancer or other diseases.","longName":"6345662v1.0:3193868v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"6345662","version":"1","preferredName":"IDH Gene Family","preferredDefinition":"A family of genes that encode enzymes that catalyze the decarboxylation of isocitrate yielding alpha-ketoglutarate and carbon dioxide. Alpha-ketoglutarate is a precursor used in the synthesis of alanine, glutamine and pyruvate, and is an important intermediate in the citric acid cycle, which is an essential metabolic pathway used by cells to produce energy through aerobic respiration. Mutations in the IDH1 and IDH2 genes are associated with several types of brain tumors.","longName":"C129260","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IDH Gene Family","conceptCode":"C129260","definition":"A family of genes that encode enzymes that catalyze the decarboxylation of isocitrate yielding alpha-ketoglutarate and carbon dioxide. Alpha-ketoglutarate is a precursor used in the synthesis of alanine, glutamine and pyruvate, and is an important intermediate in the citric acid cycle, which is an essential metabolic pathway used by cells to produce energy through aerobic respiration. Mutations in the IDH1 and IDH2 genes are associated with several types of brain tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7021694F-08D6-6F28-E053-F662850A7803","latestVersionIndicator":"Yes","beginDate":"2018-07-03","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2018-07-03","modifiedBy":"ONEDATA","dateModified":"2018-07-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3193868","version":"1","preferredName":"Mutation Abnormality","preferredDefinition":"A general term referring to single or multiple alterations in the genetic material of an organism that ranges from a single base change in a gene to the loss or addition of complete chromosomes. A mutation abnormality may be heritable or occur somatically.","longName":"C45576","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mutation Abnormality","conceptCode":"C45576","definition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D5F2496-5D1D-3EDC-E040-BB89AD43173D","latestVersionIndicator":"Yes","beginDate":"2011-02-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-02-28","modifiedBy":"ONEDATA","dateModified":"2011-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7021694F-08E4-6F28-E053-F662850A7803","latestVersionIndicator":"Yes","beginDate":"2018-07-03","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2018-07-03","modifiedBy":"MAESKEB","dateModified":"2018-07-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6345665","version":"1","preferredName":"Mutation Abnormality Status","preferredDefinition":"A condition or state at a particular time._Any change in the DNA of a cell. Mutations may be caused by mistakes during cell division, or they may be caused by exposure to DNA-damaging agents in the environment. Mutations can be harmful, beneficial, or have no effect. If they occur in cells that make eggs or sperm, they can be inherited; if mutations occur in other types of cells, they are not inherited. Certain mutations may lead to cancer or other diseases._A condition or state at a particular time.","longName":"6345665v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IDH Mutant","valueDescription":"Mutant IDH Gene Family","ValueMeaning":{"publicId":"6345666","version":"1","preferredName":"Mutant IDH Gene Family","longName":"6345666","preferredDefinition":"An altered form of an individual, organism, population, or genetic character that differs from the corresponding wild type due to one or more alterations (mutations).: A family of genes that encode enzymes that catalyze the decarboxylation of isocitrate yielding alpha-ketoglutarate and carbon dioxide. Alpha-ketoglutarate is a precursor used in the synthesis of alanine, glutamine and pyruvate, and is an important intermediate in the citric acid cycle, which is an essential metabolic pathway used by cells to produce energy through aerobic respiration. Mutations in the IDH1 and IDH2 genes are associated with several types of brain tumors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mutant","conceptCode":"C25360","definition":"An altered form of an individual, organism, population, or genetic character that differs from the corresponding wild type due to one or more alterations (mutations).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"IDH Gene Family","conceptCode":"C129260","definition":"A family of genes that encode enzymes that catalyze the decarboxylation of isocitrate yielding alpha-ketoglutarate and carbon dioxide. Alpha-ketoglutarate is a precursor used in the synthesis of alanine, glutamine and pyruvate, and is an important intermediate in the citric acid cycle, which is an essential metabolic pathway used by cells to produce energy through aerobic respiration. Mutations in the IDH1 and IDH2 genes are associated with several types of brain tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"70219500-B1C0-7552-E053-F662850A6D03","latestVersionIndicator":"Yes","beginDate":"2018-07-03","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2018-07-03","modifiedBy":"ONEDATA","dateModified":"2018-07-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"70219500-B1D9-7552-E053-F662850A6D03","beginDate":"2018-07-03","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2018-07-03","modifiedBy":"ONEDATA","dateModified":"2018-07-03","deletedIndicator":"No"},{"value":"IDH Wild Type","valueDescription":"Wild Type IDH Gene Family","ValueMeaning":{"publicId":"6345667","version":"1","preferredName":"Wild Type IDH Gene Family","longName":"6345667","preferredDefinition":"The naturally-occurring, normal, non-mutated version of a gene or genome.: A family of genes that encode enzymes that catalyze the decarboxylation of isocitrate yielding alpha-ketoglutarate and carbon dioxide. Alpha-ketoglutarate is a precursor used in the synthesis of alanine, glutamine and pyruvate, and is an important intermediate in the citric acid cycle, which is an essential metabolic pathway used by cells to produce energy through aerobic respiration. Mutations in the IDH1 and IDH2 genes are associated with several types of brain tumors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Wild Type","conceptCode":"C62195","definition":"The naturally-occurring, normal, non-mutated version of a gene or genome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"IDH Gene Family","conceptCode":"C129260","definition":"A family of genes that encode enzymes that catalyze the decarboxylation of isocitrate yielding alpha-ketoglutarate and carbon dioxide. Alpha-ketoglutarate is a precursor used in the synthesis of alanine, glutamine and pyruvate, and is an important intermediate in the citric acid cycle, which is an essential metabolic pathway used by cells to produce energy through aerobic respiration. Mutations in the IDH1 and IDH2 genes are associated with several types of brain tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"70219500-B1E6-7552-E053-F662850A6D03","latestVersionIndicator":"Yes","beginDate":"2018-07-03","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2018-07-03","modifiedBy":"ONEDATA","dateModified":"2018-07-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"70219500-B1FF-7552-E053-F662850A6D03","beginDate":"2018-07-03","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2018-07-03","modifiedBy":"ONEDATA","dateModified":"2018-07-03","deletedIndicator":"No"},{"value":"Indeterminate","valueDescription":"Indeterminate","ValueMeaning":{"publicId":"5612323","version":"1","preferredName":"Indeterminate","longName":"5612323","preferredDefinition":"Cannot distinguish between two or more possible values in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indeterminate","conceptCode":"C48658","definition":"Cannot distinguish between two or more possible values in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"45340835-3B23-7C78-E053-F662850A44F9","latestVersionIndicator":"Yes","beginDate":"2017-01-03","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-01-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7627C7B6-F28B-0746-E053-F662850A92B6","beginDate":"2018-09-18","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2018-09-18","modifiedBy":"ONEDATA","dateModified":"2018-09-18","deletedIndicator":"No"},{"value":"Not Available","valueDescription":"Unavailable","ValueMeaning":{"publicId":"5828000","version":"1","preferredName":"Unavailable","longName":"5828000","preferredDefinition":"The desired information is not available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Available","conceptCode":"C126101","definition":"The desired information is not available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4FA9603A-3882-60D4-E053-F662850A4F9D","latestVersionIndicator":"Yes","beginDate":"2017-05-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-05-16","modifiedBy":"GDEEN","dateModified":"2024-01-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D800C3D9-6FEC-7CBF-E053-4EBD850A5987","beginDate":"2022-02-14","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2022-02-14","modifiedBy":"ONEDATA","dateModified":"2022-02-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3219493","version":"1","preferredName":"Mutation Abnormality Status","preferredDefinition":"A general term referring to single or multiple alterations in the genetic material of an organism that ranges from a single base change in a gene to the loss or addition of complete chromosomes. A mutation abnormality may be heritable or occur somatically.:A condition or state at a particular time.","longName":"C45576:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mutation Abnormality","conceptCode":"C45576","definition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9FE30699-DBBB-4983-E040-BB89AD4369B1","latestVersionIndicator":"Yes","beginDate":"2011-04-01","endDate":null,"createdBy":"WHITES","dateCreated":"2011-04-01","modifiedBy":"ONEDATA","dateModified":"2011-04-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"70219500-B1A7-7552-E053-F662850A6D03","latestVersionIndicator":"Yes","beginDate":"2018-07-03","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2018-07-03","modifiedBy":"SPRINGERL","dateModified":"2022-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"NRG","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"Based on the IDH 1/2 results,","type":"Preferred Question Text","description":"Based on the IDH 1/2 results, is the patient considered to be IDH wild type or IDH mutant?","url":null,"context":"COG"},{"name":"COG CRF Text 100","type":"Alternate Question Text","description":"Overall IDH Status:","url":null,"context":"COG"},{"name":"NRG CRF TEXT 1","type":"Alternate Question Text","description":"IDH Mutation Status","url":null,"context":"NRG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"701F231B-5792-1B70-E053-F662850A8938","latestVersionIndicator":"Yes","beginDate":"2018-07-03","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2018-07-03","modifiedBy":"WISEM","dateModified":"2019-11-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}